Health care startups that raised Series D or later in California, United States
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Zipline International | South San Francisco | Series I | $1.5B | 2026-11-05 |
| Sirona Medical | San Francisco | Series D | $40.0M | 2026-10-15 |
| Suki | Redwood City | Series E | $90.0M | 2026-10-12 |
| Circle Pharma | South San Francisco | Series E | $92.5M | 2026-09-16 |
| Craif | Irvine | Series D | $24.4M | 2026-08-18 |
| Lycia Therapeutics | South San Francisco | Series D | $75.0M | 2026-06-25 |
| Element Biosciences | San Diego | Series E | $277.0M | 2026-06-09 |
| Calyxo | Pleasanton | Series F | $40.0M | 2026-04-14 |
8 rows of the CSV in 5 of its 18 columns.
- The 193 health care startups in California, United States whose last round is Series D or later have raised $38.9B in total.
- 24 of them closed their most recent round in the last 12 months, $3.9B combined.
- The largest of those rounds is Zipline International's $1.5B Series I, dated November 2026.
- Khosla Ventures is an investor in 6 of them, more than any other fund.
- Biotech is the most common other sector, with 96 companies (50%).
- 2% were founded in 2020 or later; the median founding year is 2008.
- The most common team size is 11 to 50 employees (27% of companies with a recorded size).
- 9 are unicorns, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
30 of 193| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Zipline International Unicorn | Zipline designs, manufactures, and operates drones that deliver medical products. | Hardware | South San Francisco | Series I | $1.5B | 2026-11-05 | $3.6B | Techstars, Andreessen Horowitz, Sequoia Capital +2 | 1,001 to 5,000 | 2011 |
| Sirona Medical | Sirona Medical develops cloud-native radiology workflow software for medical imaging practices. | Artificial intelligence | San Francisco | Series D | $40.0M | 2026-10-15 | $144.5M | Global Founders Capital, 8VC, GreatPoint Ventures +2 | 101 to 250 | 2018 |
| Suki | Suki builds AI tools that help clinicians with clinical documentation and administrative tasks. | Artificial intelligence | Redwood City | Series E | $90.0M | 2026-10-12 | $255.0M | Gaingels, First Round Capital, Breyer Capital +2 | 251 to 500 | 2017 |
| Circle Pharma | Circle Pharma develops bioavailable macrocyclic peptide therapeutics that target protein-protein interactions. | Biotech | South San Francisco | Series E | $92.5M | 2026-09-16 | $300.0M | Mission BioCapital, Pfizer, The Column Group +1 | 11 to 50 | 2012 |
| Craif | Craif develops a cancer diagnosis algorithm using microRNA data and machine learning. | Artificial intelligence | Irvine | Series D | $24.4M | 2026-08-18 | $68.7M | Global Brain Corporation, VentureOut, ANRI +1 | 51 to 100 | 2018 |
| Lycia Therapeutics | Lycia Therapeutics develops technology using lysosome-targeting chimeras to degrade disease-causing proteins. | Biotech | South San Francisco | Series D | $75.0M | 2026-06-25 | $301.6M | Franklin Templeton, Alexandria Venture Investments, Invus +1 | 11 to 50 | 2019 |
| Element Biosciences Unicorn | Element Biosciences develops genomic sequencing and multiomics technologies for drug discovery and diagnostic applications. | Biotech | San Diego | Series E | $277.0M | 2026-06-09 | $678.0M | RA Capital Management, Fidelity, Wellington Management +2 | 251 to 500 | 2017 |
| Calyxo | Calyxo is a medical device company that develops urology technologies for kidney stone treatment. | Health care | Pleasanton | Series F | $40.0M | 2026-04-14 | $165.4M | Questa Capital Management, Avidity Partners | 251 to 500 | 2016 |
| Numerion Labs | Numerion Labs develops artificial intelligence systems for drug discovery using deep learning algorithms. | Artificial intelligence | San Francisco | Series D | $19.8M | 2026-03-19 | $241.4M | Y Combinator, Khosla Ventures, Creative Destruction Lab +1 | 11 to 50 | 2012 |
| Varda | Varda manufactures products in microgravity in space and returns them to Earth for use. | Health care | El Segundo | Series D | $275.0M | 2026-02-17 | $603.1M | General Catalyst, Khosla Ventures, Founders Fund +2 | 101 to 250 | 2021 |
| Angitia Biopharmaceuticals | Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases. | Biotech | Westlake Village | Series D | $130.0M | 2026-02-05 | $406.0M | Legend Capital, OrbiMed, Oriza Holdings +1 | 51 to 100 | 2018 |
| Midi Health | Midi Health provides virtual care for women in midlife, including menopause and hormonal health support. | Health care | Palo Alto | Series D | $100.0M | 2026-02-03 | $252.0M | Google Ventures, City Light Capital, Icon Ventures | 101 to 250 | 2021 |
| Artera | Artera provides AI-powered virtual agents that handle voice and text communication for patient care. | Artificial intelligence | Santa Barbara | Series D | $65.0M | 2025-12-03 | $110.1M | Techstars, Freestyle Capital, Jackson Square Ventures +2 | 251 to 500 | 2015 |
| Transcarent Unicorn | Transcarent provides a healthcare platform that helps people achieve better outcomes and make cost-effective decisions. | Health care | San Francisco | Series D | $481.0M | 2025-04-08 | $905.0M | General Catalyst, Kleiner Perkins, Human Capital +1 | 1,001 to 5,000 | 2020 |
| Qventus | Qventus provides AI-driven automation that improves healthcare operations. | Artificial intelligence | Mountain View | Series D | $85.0M | 2025-01-13 | $203.0M | Y Combinator, Bessemer Venture Partners, Norwest +2 | 101 to 250 | 2012 |
| Clear Labs | Clear Labs is a biotechnology firm that uses a genomics system to simplify diagnostics. | Artificial intelligence | San Carlos | Series D | $30.0M | 2025-01-13 | $156.5M | Plug and Play, Alumni Ventures, Khosla Ventures +1 | 51 to 100 | 2014 |
| Innovaccer Unicorn | Innovaccer provides an AI cloud platform for healthcare data management and analytics. | Artificial intelligence | San Francisco | Series F | $275.0M | 2025-01-09 | $654.1M | 500 Global, Lightspeed Venture Partners, Tiger Global Management +2 | 1,001 to 5,000 | 2014 |
| Neptune Medical | Neptune Medical develops endoscopic and surgical devices. | Hardware | Burlingame | Series D | $97.0M | 2024-08-15 | $97.0M | Mighty Capital, Sonder Capital, Synergy Partners International +1 | 101 to 250 | 2016 |
| Moximed | Moximed develops therapies for patients with knee osteoarthritis. | Biotech | Hayward | Series D | $61.0M | 2024-08-13 | $244.2M | New Enterprise Associates, Vertex Ventures, Cormorant Asset Management +1 | 11 to 50 | 2006 |
| Truvian Sciences | Truvian Sciences develops an automated benchtop system for lab-accurate blood testing. | Biotech | San Diego | Series D | $74.0M | 2024-07-17 | $208.1M | General Catalyst, GreatPoint Ventures, Tao Capital Partners +2 | 101 to 250 | 2015 |
| NeuSpera Medical | NeuSpera Medical manufactures and sells implantable neuromodulation medical devices. | Health care | San Jose | Series D | $23.0M | 2024-07-15 | $134.9M | Alumni Ventures, MedTech Innovator, Windham Venture Partners +1 | 11 to 50 | 2013 |
| Sidecar Health Unicorn | Sidecar Health offers employer health plans that give members pricing transparency and financial incentives for care decisions. | Fintech | Covina | Series D | $165.0M | 2024-06-26 | $328.0M | Tiger Global Management, Menlo Ventures, Drive Capital +1 | 251 to 500 | 2018 |
| BillionToOne Unicorn | BillionToOne offers genetic testing that detects disease through precision diagnostics. | Biotech | Menlo Park | Series D | $130.0M | 2024-06-21 | $425.9M | Y Combinator, 500 Global, UpHonest Capital +1 | 501 to 1,000 | 2016 |
| Clarify Health Solutions Unicorn | Clarify Health Solutions builds an intelligence platform that delivers healthcare insights. | Artificial intelligence | San Francisco | Series D | $150.0M | 2022-04-05 | $328.0M | Insight Partners, Spark Capital, SoftBank Vision Fund +2 | 101 to 250 | 2015 |
| DNAnexus | DNAnexus provides a cloud platform and network for scientific collaboration and research. | Biotech | Mountain View | Series H | $200.0M | 2022-03-08 | $472.6M | Google Ventures, First Round Capital, Microsoft | 101 to 250 | 2009 |
| Synthego | Synthego provides genome engineering services and CRISPR tools for life science research. | Artificial intelligence | Redwood City | Series E | $200.0M | 2022-02-17 | $459.7M | Intel Capital, Founders Fund, Menlo Ventures +2 | 101 to 250 | 2012 |
| Lark | Lark is a digital health company that delivers virtual care through AI coaching, smart devices, and remote monitoring. | Artificial intelligence | Mountain View | Series D | $100.0M | 2021-10-13 | $195.7M | Lightspeed Venture Partners, Franklin Templeton, Golden Seeds +2 | 101 to 250 | 2011 |
| Evidation Health Unicorn | Evidation Health enables people to participate in better health outcomes. | Health care | San Mateo | Series E | $153.0M | 2021-03-22 | $259.0M | B Capital, Asset Management Ventures (AMV), G Squared +2 | 101 to 250 | 2012 |
| LeanTaaS | LeanTaaS is a software company that uses data science to improve hospital and clinic operations. | Artificial intelligence | Santa Clara | Series D | $130.0M | 2020-12-10 | $237.7M | Insight Partners, Goldman Sachs, Goldman Sachs Merchant Banking Division +1 | 251 to 500 | 2010 |
| Heal | Heal provides in-home primary care with doctor house calls, telemedicine, and remote monitoring for seniors. | Health care | Los Angeles | Series D | $100.0M | 2020-07-29 | $168.0M | Plug and Play, Alumni Ventures, Fidelity +1 | 251 to 500 | 2014 |
Table 1. Health care startups that raised Series D or later in California, United States: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 193.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Zipline International Unicorn | Zipline designs, manufactures, and operates drones that deliver medical products. | Hardware | South San Francisco | Series I | $1.5B | 2026-11-05 | $3.6B | Techstars, Andreessen Horowitz, Sequoia Capital +2 | 1,001 to 5,000 | 2011 |
| 2 | Element Biosciences Unicorn | Element Biosciences develops genomic sequencing and multiomics technologies for drug discovery and diagnostic applications. | Biotech | San Diego | Series E | $277.0M | 2026-06-09 | $678.0M | RA Capital Management, Fidelity, Wellington Management +2 | 251 to 500 | 2017 |
| 3 | Varda | Varda manufactures products in microgravity in space and returns them to Earth for use. | Health care | El Segundo | Series D | $275.0M | 2026-02-17 | $603.1M | General Catalyst, Khosla Ventures, Founders Fund +2 | 101 to 250 | 2021 |
| 4 | Angitia Biopharmaceuticals | Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases. | Biotech | Westlake Village | Series D | $130.0M | 2026-02-05 | $406.0M | Legend Capital, OrbiMed, Oriza Holdings +1 | 51 to 100 | 2018 |
| 5 | Midi Health | Midi Health provides virtual care for women in midlife, including menopause and hormonal health support. | Health care | Palo Alto | Series D | $100.0M | 2026-02-03 | $252.0M | Google Ventures, City Light Capital, Icon Ventures | 101 to 250 | 2021 |
| 6 | Circle Pharma | Circle Pharma develops bioavailable macrocyclic peptide therapeutics that target protein-protein interactions. | Biotech | South San Francisco | Series E | $92.5M | 2026-09-16 | $300.0M | Mission BioCapital, Pfizer, The Column Group +1 | 11 to 50 | 2012 |
| 7 | Suki | Suki builds AI tools that help clinicians with clinical documentation and administrative tasks. | Artificial intelligence | Redwood City | Series E | $90.0M | 2026-10-12 | $255.0M | Gaingels, First Round Capital, Breyer Capital +2 | 251 to 500 | 2017 |
| 8 | Lycia Therapeutics | Lycia Therapeutics develops technology using lysosome-targeting chimeras to degrade disease-causing proteins. | Biotech | South San Francisco | Series D | $75.0M | 2026-06-25 | $301.6M | Franklin Templeton, Alexandria Venture Investments, Invus +1 | 11 to 50 | 2019 |
| 9 | Artera | Artera provides AI-powered virtual agents that handle voice and text communication for patient care. | Artificial intelligence | Santa Barbara | Series D | $65.0M | 2025-12-03 | $110.1M | Techstars, Freestyle Capital, Jackson Square Ventures +2 | 251 to 500 | 2015 |
| 10 | Sirona Medical | Sirona Medical develops cloud-native radiology workflow software for medical imaging practices. | Artificial intelligence | San Francisco | Series D | $40.0M | 2026-10-15 | $144.5M | Global Founders Capital, 8VC, GreatPoint Ventures +2 | 101 to 250 | 2018 |
Table 2. Health care startups that raised Series D or later in California, United States: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Khosla Ventures | Venture capital firm | Menlo Park, United States | 6 | 3% | 2 | Numerion Labs, Varda |
| 2 | Y Combinator | Startup accelerator | Mountain View, United States | 4 | 2% | 1 | Numerion Labs |
| 3 | Techstars | Startup accelerator | New York, United States | 3 | 2% | 2 | Zipline International, Artera |
| 4 | Fidelity | Investment bank | Boston, United States | 3 | 2% | 2 | Zipline International, Element Biosciences |
| 5 | First Round Capital | Venture capital firm | Philadelphia, United States | 3 | 2% | 1 | Suki |
| 6 | RA Capital Management | Startup incubator | Boston, United States | 3 | 2% | 1 | Element Biosciences |
| 7 | B Capital | Venture capital firm | Manhattan Beach, United States | 3 | 2% | 1 | Numerion Labs |
| 8 | General Catalyst | Venture capital firm | San Francisco, United States | 3 | 2% | 1 | Varda |
| 9 | OrbiMed | Private equity firm | New York, United States | 3 | 2% | 1 | Angitia Biopharmaceuticals |
| 10 | BlackRock | Investment bank | New York, United States | 3 | 2% | ||
| 11 | Alumni Ventures | Angel group | Manchester, United States | 3 | 2% | ||
| 12 | Menlo Ventures | Venture capital firm | Menlo Park, United States | 3 | 2% | ||
| 13 | New Enterprise Associates | Venture capital firm | Menlo Park, United States | 3 | 2% | ||
| 14 | Sequoia Capital | Venture capital firm | Menlo Park, United States | 2 | 1% | 1 | Zipline International |
| 15 | 8VC | Venture capital firm | Austin, United States | 2 | 1% | 1 | Sirona Medical |
Table 3. Health care startups that raised Series D or later in California, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Biotech | 96 | 50% | $16.8B |
| Software | 35 | 18% | $7.4B |
| Artificial intelligence | 19 | 10% | $4.2B |
| Hardware | 7 | 4% | $3.9B |
| Fintech | 4 | 2% | $1.4B |
| Education | 1 | 1% | $73.0M |
| Commerce | 1 | 1% | $49.0M |
| Cybersecurity | 1 | 1% | $86.5M |
Table 4. Health care startups that raised Series D or later in California, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series D+ | 193 | 100% | $45.0M |
Table 5. Health care startups that raised Series D or later in California, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| San Francisco | 24 | 12% |
| San Diego | 19 | 10% |
| Redwood City | 14 | 7% |
| South San Francisco | 12 | 6% |
| Mountain View | 12 | 6% |
| Menlo Park | 8 | 4% |
| Irvine | 7 | 4% |
| Palo Alto | 7 | 4% |
| San Mateo | 7 | 4% |
| Sunnyvale | 7 | 4% |
| San Jose | 5 | 3% |
| Hayward | 5 | 3% |
Table 6. Health care startups that raised Series D or later in California, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 1 | 4% | $1.5B |
| October 2026 | 4 | 17% | $232.7M |
| September 2026 | 2 | 8% | $367.5M |
| August 2026 | 1 | 4% | $24.4M |
| July 2026 | 1 | 4% | $120.0M |
| June 2026 | 2 | 8% | $352.0M |
| May 2026 | 2 | 8% | $109.0M |
| April 2026 | 2 | 8% | $50.0M |
| March 2026 | 1 | 4% | $19.8M |
| February 2026 | 3 | 12% | $505.0M |
| January 2026 | 2 | 8% | $507.0M |
| December 2025 | 2 | 8% | $90.0M |
| November 2025 | 1 | 4% | $45.0M |
Table 7. Health care startups that raised Series D or later in California, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 21 | 11% | $3.8B |
| 2025 | 19 | 10% | $2.2B |
| 2024 | 10 | 5% | $823.3M |
| 2023 | 6 | 3% | $427.0M |
| 2022 | 9 | 5% | $930.0M |
| 2021 | 20 | 10% | $2.8B |
Table 8. Health care startups that raised Series D or later in California, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2020 to 2022 | 4 | 2% |
| 2015 to 2019 | 38 | 20% |
| 2010 to 2014 | 46 | 24% |
| Before 2010 | 105 | 54% |
Table 9. Health care startups that raised Series D or later in California, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 13 | 7% |
| 11 to 50 | 51 | 27% |
| 51 to 100 | 50 | 26% |
| 101 to 250 | 35 | 18% |
| 251 to 500 | 20 | 11% |
| 501 to 1,000 | 7 | 4% |
| 1,001 to 5,000 | 12 | 6% |
| 5,001 to 10,000 | 1 | 1% |
| 10,001 or more | 1 | 1% |
Table 10. Health care startups that raised Series D or later in California, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its most recent funding round is Series D or later and its headquarters is in California, United States. On 16 November 2026 that is 193 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 30 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 193 rows: 16 have no round amount, 0 no city and 14 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in California, United States whose last round is Series D or later are on the list?
- 193, in the file dated 16 November 2026. 24 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 193 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.